Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 196

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 196
---
Property,
Plant and Equipment”. Whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted
cash flows expected to be generated by the assets. If such asset is impaired, the impairment to be recognized is measured by the amount
by which the carrying amount of the asset exceeds its fair value. Assets to be disposed of are reported at the lower of the carrying
amount or fair value less costs to sell. During the period ended July 23, 2024, and years ended December 31, 2023, and 2022, no impairment
losses have been identified.

| f. | Research and development expenses: |

Research and
development expenses are charged to the statement of comprehensive loss as incurred.

| g. | Severance pay: |

The Company’s
liability for severance pay is subject to Section 14 of Israel’s the Severance Compensation Act, 1963 (“Section 14”),
pursuant to which all Subsidiary’s employees are included under Section 14, and are entitled only to monthly deposits, at a rate
of 8.33% of their monthly salary, made in the employee’s name with insurance companies. Under Israeli employment law, payments in
accordance with Section 14 release the subsidiary from any future severance payments in respect of those employees. The Company has made
all of the required payments as of December 31, 2023 and as of July 23, 2024.

The fund is
made available to the employee at the time the employer-employee relationship is terminated, regardless of cause of termination.

The severance
pay liabilities and deposits under Section 14 are not reflected in the balance sheets as the severance pay risks have been irrevocably
transferred to the severance funds.

| h. | Income taxes: |

The Company
accounts for income taxes in accordance with ASC No. 740, “Income Taxes”, (“ASC 740”) which prescribes the use
of the liability method whereby deferred tax asset and liability account balances are determined based on differences between financial
reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the
differences are expected to reverse.

The Company
provides a valuation allowance, if necessary, to reduce deferred tax assets